An interventional study of lifetyle corrections and CPAP and CPAP in Primary Open Angle Glaucoma, Obstructive Sleep Apnea and Obesity, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-03-03.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Glaucoma, Open-Angle with a site in Egypt — 5 open to participants now, 6 under way, none of them phase 3. Glaucoma, Open-Angle · Egypt.
Among the 25 studies in Glaucoma, Open-Angle with a site in Egypt, this one is the 11th largest by planned enrollment of the 17 interventional ones that give a count, is one of 3 that started in 2026, is one of 12 with no phase, and was the 22nd registered.
924 studies on the registry are indexed under Glaucoma, Open-Angle; 115 are open to participants now.
Browse Glaucoma, Open-Angle studies →5 of the 25 studies in Glaucoma, Open-Angle with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 65–75 · Women only
Minia University Hospital · Sites in Egypt
Minia University · Sites in Egypt
Ages 40+
Sohag University · Sites in Egypt
Ages 30+ · Healthy volunteers
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 82 Glaucoma, Open-Angle studies recruiting now, 63 (77%) set no upper age limit and 5 (6%) stop at 75 or younger; 5 take children under 18; 11 take healthy volunteers.
This study: 30 Years to 50 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 40 is below the median of 80 across 692 interventional studies indexed under Glaucoma, Open-Angle.
Median enrollment 46 across the 17 interventional studies, 78 across the 8 observational. Of the 15 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 25 have an industry lead sponsor. The 10 most frequent:
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Cairo University has 6 studies filed under Glaucoma, Open-Angle — fewer than ten, so there is no comparison to draw.
3 of the studies in Glaucoma, Open-Angle with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07454447Minia University HospitalUBM Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma | 2026-11 |
| NCT07599241Cairo UniversityAdditive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues | 2026-12-15 |
| NCT07119905Sohag UniversityAssociation Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patients in Sohag University Hospital | 2027-01-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 25 studies in Glaucoma, Open-Angle with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
glaucoma is prevalent among obstructive sleep apnea (OSA). contnous passive airway pressure is main treatment of OSA. lifestyle corrections also recommended
forty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved and divided to group I or group II (number of patients will be twenty in every group) for three month. both groups will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
cardiac patients renal patients hepatic patients
twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group I will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.
Behavioral: lifetyle corrections and CPAP
twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group II will apply CPAP during night sleeping daily for three month.
Other: CPAP
twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group I will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.
twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group II will apply CPAP during night sleeping daily for three month.
Intraocular pressure
it will be measured by tonometery
Time frame: it will be measured after 12 weeks
apnea hypopnea index
it is an indicator on numbe rof apnea during sleep
Time frame: It will be measured after 12 weeks
Epowrth sleepiness scale
a questioanire assess rate of sleepiness
Time frame: It will be measured after 12 weeks
body mass index
it assesed on empty bladder and bowel
Time frame: It will be measured after 12 weeks
waist circumference
it will be assesed at umbilical level
Time frame: it will be measured after 12 weeks
neck circumferfence
it is a measures of local fat around neck
Time frame: It will be measured after 12 weeks
glaucoma related quality of life questioanire
it is 15-item questioanire assessing life quality in qlaucoma
Time frame: It will be measured after 12 weeks
Started Feb 2026 (actual). Primary completion is estimated for Jul 2026, 5 months after the start.
Of 101 non-industry interventional studies with no phase under Glaucoma, Open-Angle, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 57. This study's planned 5 months is below that.
Counting every sponsor, half of 171 studies reached it within 35 months; a quarter within 19 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.